Home Stock

Stock Research: Pro Medicus

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Pro Medicus

ASX:PME AU000000PME8
50
  • Value
    6
  • Growth
    71
  • Safety
    Safety
    11
  • Combined
    18
  • Sentiment
    42
  • 360° View
    360° View
    50
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Pro Medicus Limited is a healthcare informatics company providing medical imaging software and services. It operates in the medical imaging software industry with products like Visage RIS, Visage 7, and Visage Ease. The company serves hospitals, imaging centers, and healthcare groups in Australia, North America, and Europe. In the last fiscal year, the company had a market cap of $22457 million, profits of $111 million, and revenue of $111 million.

more

ANALYSIS: With an Obermatt 360° View of 50 (better than 50% compared with alternatives), overall professional sentiment and financial characteristics for the stock Pro Medicus are above average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Pro Medicus. The consolidated Growth Rank has a good rank of 71, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 71% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 6 means that the share price of Pro Medicus is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 94% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 11, which means that the company has a riskier financing structure than 89% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 42, indicating professional investors are more pessimistic about the stock than for 58% of alternative investment opportunities. ...read more

more
Strongest Rank Market Pulse
Weakest Rank Leverage
Country Australia
Industry Health Care Technology
Size Medium
Website promed.com.au
Index
ASX 100
ASX 200
ASX 300
ASX 50
Pro Medicus stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 23-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
6 5 10 17
Growth
71 99 97 87
Safety
Safety
11 11 83 83
Sentiment
42 81 66 54
360° View
360° View
50 50 78 62
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
59 5 15 13
Opinions Change
83 91 40 50
Pro Holdings
n/a 83 84 42
Market Pulse
1 82 89 90
Sentiment
42 81 66 54
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
6 5 10 17
Growth
71 99 97 87
Safety Safety
11 11 83 83
Combined
18 18 86 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
1 1 1 2
Price vs. Earnings (P/E)
13 3 10 14
Price vs. Book (P/B)
3 1 1 3
Dividend Yield
51 48 57 64
Value
6 5 10 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
93 96 81 46
Profit Growth
59 64 60 62
Capital Growth
72 65 89 94
Stock Returns
1 99 87 81
Growth
71 99 97 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
95 91 89 73
Refinancing
20 17 11 11
Liquidity
15 15 91 91
Safety Safety
11 11 83 83

Similar Stocks

Discover high‑ranked alternatives to Pro Medicus and broaden your portfolio horizons.

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Sinopharm

HKG:1099
Country: China
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

West African Resources

ASX:WAF
Country: Australia
Industry: Gold Production
Size: Medium
Full Stock Analysis

M3

TYO:2413
Country: Japan
Industry: Health Care Technology
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews